Who owns SIGY - Sigyn Therapeutics, Inc. - COMMON STOCK, PAR VALUE $0.0001 based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Sigyn Therapeutics, Inc. - COMMON STOCK, PAR VALUE $0.0001 (SIGY) Institutional Ownership

Q: What is CUSIP 82674U205?

CUSIP 82674U205 is the security identifier used in SEC filing datasets for SIGY - Sigyn Therapeutics, Inc. - COMMON STOCK, PAR VALUE $0.0001.

CUSIP: 82674U205

13F Institutional Holders and Ownership History

Type / Class: Equity / COMMON STOCK, PAR VALUE $0.0001
Symbol: SIGY on OTC
Shares outstanding: 1,606,977
Price per share: $0.20

Investment Quick Answers

What is CUSIP 82674U205?
CUSIP 82674U205 identifies SIGY - Sigyn Therapeutics, Inc. - COMMON STOCK, PAR VALUE $0.0001 in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Significant Owners of Sigyn Therapeutics, Inc. - COMMON STOCK, PAR VALUE $0.0001 (SIGY) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Brio Capital Master Fund Ltd.	10%	0%	$321,074	+$3,210	160,537	+1%	Brio Capital Master Fund Ltd.	31 Dec 2025